December 6, 2015 Development of a Patient-Reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase
January 6, 2015 Patient-Reported Outcomes In Cancer Drug Development And US Regulatory Review: Perspectives From Industry, The Food And Drug Administration, And The Patient
January 6, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarker June 1, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarke
Critical Path Institute Launches New Neonatal Consortium May 19, 2015 Critical Path Institute Launches New Neonatal Consortium The International Neonatal Consortium (INC) aims to accelera
June 5, 2015 Migrating a PRO Instrument This webinar provides a detailed description of the process for conducting paper to ePRO migration, mode-specific migrations, usab
C-Path Selected as Host For New TB Clinical Trial Data-Sharing Platform May 4, 2015 Host For New TB Clinical Trial Data-Sharing Platform Selected TUCSON, Ariz., May 4, 2015 — The non-profit Critical P
Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers April 27, 2015 Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers F
The TREAT-NMD Advisory Committee for Therapeutics (TACT): An Innovative de-Risking Model to Foster Orphan Drug Development
